Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors

Jooeun Bae; Teru Hideshima; Yu-Tzu Tai; Yan Song; Paul Richardson; Noopur Raje; Nikhil C Munshi; Kenneth C Anderson

doi:10.1038/s41375-024-02185-y

Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors

Leukemia. 2024 May;38(5):1189-1190. doi: 10.1038/s41375-024-02185-y.

Authors

Jooeun Bae^{1

2}, Teru Hideshima^{3

4}, Yu-Tzu Tai^{3

4}, Yan Song^{3

4}, Paul Richardson^{3

4}, Noopur Raje^{4

5}, Nikhil C Munshi^{3

4

6}, Kenneth C Anderson^{3

4}

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
² Harvard Medical School, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
³ Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.
⁵ Massachusetts General Hospital, Boston, MA, USA.
⁶ VA Boston Healthcare System, Boston, MA, USA.

PMID: 38622290
DOI: 10.1038/s41375-024-02185-y

No abstract available

Publication types

Published Erratum